semaglutide and heart disease cardiovascular outcomes align more closely with attained dose than achieved weight loss STEP-HFpEF Trial

This CardioNerds Digital Health series is made possible by contributions of stellar fellow leads and expert faculty from several programs, led by series co-chairs, Dr

Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone

And it creates a record that helps you and your healthcare provider track your protocol over time

Higher Discontinuation Rates: The triplet therapy group had a 28.3% discontinuation rate due to tolerability issues and adverse events, significantly higher than the 4% to 10% seen in the semaglutide-only or semaglutide + trevogrumab groups

Energy balance and mitochondrial pathways

Occasionally shifting your injection day by a few hours due to travel is acceptable